Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Positive findings from fully enrolled cohorts in non-small cell lung cancer and metastatic breast cancer from ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR™) Study will be presented in poster sessions at the 2019 ASCO Annual Meeting. In addition, the study is being expanded to include patients with active brain metastases and three new drug therapies. Learn more.
Use of the ASCO Guidelines App may provide credit for up to 2 MIPS Improvement Activities! With this app you can search selected ASCO Clinical Practice Guidelines with the tap of your finger. Expert recommendations, algorithms, and calculators help make decisions at the point-of-care.
ASCO membership helps you gain insight into best practices for cancer care teams whether you are part of a large academic institution or a small private clinic. With dedicated membership categories for Advance Practice Providers and Practice Administrators, we recognize the roles that all team members play in the delivery of high-quality cancer care. With resources such as Journal of Oncology Practice® and Advanced Practitioners Certificate Programs you can enhance your multidisciplinary team’s effectiveness and improve performance.
A new study published today in the Journal of Oncology Practice (JOP) reveals the findings of a 2018 American Society of Clinical Oncology (ASCO) Oncology Workforce survey on oncologists’ perceptions and practice behaviors related to diet, physical activity, and weight management in people with cancer – during and after active treatment. The survey finds oncologists’ attention to patients’ weight management and diet is high, but referrals to support lifestyle changes are infrequent.
On May 16, 2019, the Food and Drug Administration approved dalteparin sodium (FRAGMIN®, Pfizer, Inc.) to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients 1 month of age and older. Read more. 
The Centers for Medicare & Medicaid Services (CMS) is hosting a webinar on Thursday, May 23 from 1:00 – 2:00 PM ET to provide an overview of the Improvement Activities performance category of the Merit-based Incentive Payment System (MIPS) in 2019. CMS subject matter experts will provide a brief overview of MIPS and discuss the following Improvement Activities Performance Category topics:
The Centers for Disease Control and Prevention recently clarified that its opioid prescribing guideline is not intended to deny clinically-appropriate opioid therapy to patients with pain from conditions such as cancer and sickle cell disease. In a new ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis stresses that swift action is needed to correct policies that limit opioid access for critical pain management, cautioning that we can’t have one national crisis become two.
On May 15, 2019, the Food and Drug Administration approved venetoclax (VENCLEXTA®, AbbVie Inc. and Genentech Inc.) for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Read more.